Healthcare

This may help tick the clock: ReWalk Robotics Ltd. (NASDAQ: RWLK)

ReWalk Robotics Ltd. (NASDAQ: RWLK) spotted trading -79.51% off 52-week high price. On the other end, the stock has been noted 11.62% away from the low price over the last 52-weeks. The stock changed -3.05% to recent value of $2.07. The stock transacted 78806 shares during most recent day however it has an average volume of 117.22K shares. The company has 8.3M of outstanding shares and 7M shares were floated in the market.

ReWalk Robotics Ltd. (RWLK) recently reported its financial results for the three and nine months ended September 30, 2019.

Third Quarter 2019 Financial Results

Total revenue was $1.2M for the third quarter of 2019, contrast to $1.6M during the previous year quarter. 12 ReWalk units were placed during the third quarter of 2019, contrast to 21 units in the previous year quarter. Nine ReWalk Personal units were placed in Europe, and three ReWalk Personal Units were placed in the U.S., during the third quarter of 2019. Five ReStore units were placed during the third quarter in the U.S.

Gross margin was 53% during the third quarter of 2019, contrast to 47% in the third quarter of 2018. The increase was primarily attributable to higher average selling price Because of a change in sales mix of our ReWalk Personal device and less costs related to inventory write-off.

Total operating expenses in the third quarter of 2019 reduced to $3.7M, contrast to $4.9M in the previous year period mainly Because of reduced costs associated with the development and clinical study costs of our ReStore Exo-suit, and by lower personnel and personnel-related costs and consulting expenses as result of our cost reduction efforts.

Net loss was $3.4M for the third quarter of 2019, contrast to a net loss of $4.5M in the third quarter of 2018.

According to the most recent quarter its current ratio was 2.7 that represents company’s ability to meet its current financial obligations. The price moved ahead of -9.87% from the mean of 20 days, -13.03% from mean of 50 days SMA and performed -37.02% from mean of 200 days price. Company’s performance for the week was -13.25%, -11.00% for month and YTD performance remained -4.40%.